Royce & Associates’s MiMedx Group MDXG Stock Holding History
Bought
Maintained
Sold
Other funds holding MDXG
EWM
TI
VCM
PCMI
NCM
FLAM
Royce & Associates's MDXG Position: Q1 2026 in Review
Royce & Associates opened a new position in MiMedx Group (MDXG) in Q1 2026: 14,720 shares worth $58.1K. The stake represents ﹤0.01% of the portfolio and ranks #770 among its holdings. This is a return to the name: Royce & Associates previously reported a position in MDXG as recently as Q1 2025.
Royce & Associates first reported a position in MDXG in Q1 2018 and has held it in 15 quarters since. The position peaked at $8.46M in Q4 2024. 237 funds tracked by Wall St. Rank hold MDXG as of Q1 2026.
- Royce & Associates held 14,720 shares of MiMedx Group worth $58.1K as of Q1 2026.
- MiMedx Group was a new Royce & Associates position in Q1 2026.
- MiMedx Group made up ﹤0.01% of Royce & Associates's portfolio in Q1 2026, its #770 holding.
- Royce & Associates first reported a position in MiMedx Group in Q1 2018 and has held it in 15 quarters since.
- Royce & Associates's MiMedx Group position peaked at $8.46M in Q4 2024.
- 237 funds tracked by Wall St. Rank held MiMedx Group as of Q1 2026.
Based on Royce & Associates's 13F filing for Q1 2026, filed 12 May 2026.